Assembly生物

ASMB NASDAQ
12.49
+0.21
+1.71%
盘后: 12.49 0 0.00% 17:00 08/16 EDT
开盘
12.40
昨收
12.28
最高
12.79
最低
12.30
成交量
13.48万
成交均量(3M)
27.20万
52周最高
41.00
52周最低
11.49
换手率
0.52%
市值
3.21亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Assembly生物 ASMB股票价格,Assembly生物股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has discovered various core protein Allosteric Modulators (CpAMs), which are small molecules that directly target and allosterically modulate the HBV core (HBc) protein. Its Microbiome Program consists of an integrated platform that includes a strain identification and selection process, methods for strain isolation and growth under current good manufacturing practice conditions, and a delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal (GI) tract. The lead product candidate from this platform, AB-M101, is in development for the treatment of clostridium difficile-infections.
展开 >

最近浏览

名称
价格
涨跌幅